ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1057–1068 of 2020 project topics
Gut Microbiome-Metabolomics Integration Diagnostic Service
Laboratory service combining 16S/shotgun metagenomics with fecal metabolomics to deliver actionable microbiome health reports for nutraceutical and pharmaceutical companies. Creates B2B2C revenue through partnerships with DTC health platforms and clinical validation for microbiome-targeting drug candidates.
Multi-Omics Integration in Genetics Click to view more details →
Multi-Omics Patient Data Harmonization and Integration Platform
Enterprise middleware solution that standardizes and integrates genomic, proteomic, metabolomic, and clinical data across healthcare systems and research institutions. Generates licensing and data management fees while reducing integration costs for hospitals implementing precision medicine initiatives.
Multi-Omics Integration in Genetics Click to view more details →
AI-Powered Immune Cell-Omics Profiling for Immunotherapy
Integrated platform combining single-cell transcriptomics, TCR sequencing, and plasma proteomics to predict immunotherapy response and identify optimal treatment combinations. Delivers revenue through licensing to oncology centers and enabling biomarker discovery partnerships with biopharmaceutical companies.
Multi-Omics Integration in Genetics Click to view more details →
Genetic Risk-Omics Stratification Commercial Laboratory Network
CLIA-certified laboratory service integrating polygenic risk scores with multi-omics biomarkers to provide comprehensive cardiovascular and metabolic disease risk assessment. Scales revenue through insurance reimbursement, direct-to-consumer testing, and employer wellness program partnerships.
Multi-Omics Integration in Genetics Click to view more details →
BRAF and RAS Mutation Testing in Thyroid Nodules
Developing molecular testing for BRAF V600E and RAS mutations in thyroid fine needle aspirates for preoperative malignancy risk stratification.
Genetic Basis of Thyroid Cancer Click to view more details →
RET Fusion Detection in Papillary Thyroid Cancer
Identifying RET gene fusions using RT-PCR and sequencing in papillary thyroid cancers for targetable driver discovery and kinase inhibitor therapy.
Genetic Basis of Thyroid Cancer Click to view more details →
Hereditary Thyroid Cancer Gene Panel Testing
Testing RET, DICER1, PTEN, APC, and other genes predisposing to hereditary thyroid cancer for family-based surveillance recommendations.
Genetic Basis of Thyroid Cancer Click to view more details →
ThyroSeq Molecular Classifier Validation
Validating next-generation sequencing-based molecular classifiers for differentiating benign from malignant thyroid nodules with indeterminate cytology.
Genetic Basis of Thyroid Cancer Click to view more details →
TP53 and PTEN Mutation SaaS Platform for Risk Stratification
A cloud-based diagnostic platform that identifies TP53 and PTEN mutations in thyroid cancer samples to predict aggressive phenotypes and treatment resistance. This enables oncologists to stratify patients into high-risk groups, improving treatment selection and justifying premium reimbursement rates for precision therapies.
Genetic Basis of Thyroid Cancer Click to view more details →
TERT Promoter Mutation Commercial Testing Service and Database
A high-throughput laboratory testing service that detects TERT promoter mutations as a prognostic biomarker in thyroid cancer with rapid turnaround and integrated data analytics. This service generates recurring revenue through specimen processing fees while providing actionable prognostic insights that support personalized treatment planning.
Genetic Basis of Thyroid Cancer Click to view more details →
AI-Powered Thyroid Cancer Genomic Interpretation and Reporting Tool
An artificial intelligence platform that analyzes multi-gene sequencing data from thyroid tumors to provide automated, clinically actionable genomic reports with treatment recommendations. The software generates subscription-based revenue while reducing manual curation costs and enabling pathologists to process more cases efficiently.
Genetic Basis of Thyroid Cancer Click to view more details →
Next-Generation Sequencing Panel Targeting Thyroid-Specific Driver Mutations
A proprietary targeted sequencing kit designed to detect thyroid cancer-specific mutations including BRAF, RAS, RET, TP53, and PTEN with optimized coverage and reduced costs. This commercial product captures market share from broader cancer panels by offering superior sensitivity and specificity, commanding premium pricing and licensing fees.
Genetic Basis of Thyroid Cancer Click to view more details →